BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31912104)

  • 1. Ovarian metastases reported after adjuvant laparoscopic oophorectomies in breast cancer.
    Cristian DA; Grama FA; Becheanu G; Popa I; Bratu AM; Burcoş T; Poalelungi CV; Şurlin V
    Rom J Morphol Embryol; 2019; 60(3):913-920. PubMed ID: 31912104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.
    Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ
    J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metastases to the breast from non-mammary malignancies: a clinicopathologic study of 28 cases].
    Zhou S; Yu B; Cheng Y; Xu X; Shui R; Bi R; Lu H; Tu X; Yang W
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):231-5. PubMed ID: 24915812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of immunohistochemical markers in primary lung and breast cancers enriched for triple-negative tumours.
    Provenzano E; Byrne DJ; Russell PA; Wright GM; Generali D; Fox SB
    Histopathology; 2016 Feb; 68(3):367-77. PubMed ID: 26118394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary.
    Tornos C; Soslow R; Chen S; Akram M; Hummer AJ; Abu-Rustum N; Norton L; Tan LK
    Am J Surg Pathol; 2005 Nov; 29(11):1482-9. PubMed ID: 16224215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report.
    Mori R; Futamura M; Morimitsu K; Saigo C; Miyazaki T; Yoshida K
    World J Surg Oncol; 2017 Jun; 15(1):117. PubMed ID: 28662703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of cytokeratin 7 and 20 in ovarian metastatic carcinomas].
    Dai L; Song Q; Li L; Zhong D; Hui Y
    Zhonghua Bing Li Xue Za Zhi; 2001 Apr; 30(2):114-7. PubMed ID: 11866966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary.
    Vang R; Gown AM; Zhao C; Barry TS; Isacson C; Richardson MS; Ronnett BM
    Am J Surg Pathol; 2007 Jun; 31(6):854-69. PubMed ID: 17527072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New methods to improve the safety assessment of cryopreserved ovarian tissue for fertility preservation in breast cancer patients.
    Rodríguez-Iglesias B; Novella-Maestre E; Herraiz S; Díaz-García C; Pellicer N; Pellicer A
    Fertil Steril; 2015 Dec; 104(6):1493-502.e1-2. PubMed ID: 26364839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
    McCluggage WG; Young RH
    Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folliculotropic Cutaneous Metastases and Lymphangitis Carcinomatosa: When Cutaneous Metastases of Breast Carcinoma Are Mistaken for Cutaneous Infections.
    Paolino G; Panetta C; Didona D; Donati M; Donati P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):154-7. PubMed ID: 27477179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasms involving the ovary.
    Monteagudo C; Merino MJ; LaPorte N; Neumann RD
    Hum Pathol; 1991 Apr; 22(4):368-72. PubMed ID: 2050370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastases to the Breast from Extramammary Nonhematological Malignancies: Case Series.
    Wan X; Zhang H; Zhang Y; Peng Y
    Int J Gen Med; 2020; 13():1105-1114. PubMed ID: 33209053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.
    Logani S; Oliva E; Amin MB; Folpe AL; Cohen C; Young RH
    Am J Surg Pathol; 2003 Nov; 27(11):1434-41. PubMed ID: 14576476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of laparoscopy in the evaluation of the adnexa in patients with stage IV breast cancer.
    Quan ML; Fey J; Eitan R; Abu-Rustum NR; Barakat RR; Borgen PI; Gemignani ML
    Gynecol Oncol; 2004 Jan; 92(1):327-30. PubMed ID: 14751178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of caveolin-1, thyroid transcription factor-1, and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin.
    Tsao SC; Su YC; Wang SL; Chai CY
    Kaohsiung J Med Sci; 2007 Jul; 23(7):325-31. PubMed ID: 17606426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms.
    Bejarano PA; Nikiforov YE; Swenson ES; Biddinger PW
    Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):189-94. PubMed ID: 10981870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.